Table: Delta-Fly Pharma - 6-MTH parent results

Delta-Fly Pharma

12/11/2020 06:00

Nov 12 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2020        Sep 30, 2019       Mar 31, 2021  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            100 mln                               300 mln     
                                                       (+200.0 pct)  
  Operating     loss 463 mln        loss 725 mln       loss 850 mln  
  Recurring     loss 463 mln        loss 729 mln       loss 850 mln  
  Net           loss 464 mln        loss 731 mln       loss 850 mln  
  EPS          loss 103.22 yen     loss 165.18 yen   loss 188.70 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T